Document is current
Any future updates will be listed below
-
Authors
Skinner, Owen S.
Blanco-Fernández, Joan https://orcid.org/0000-0001-7384-320X
Goodman, Russell P. https://orcid.org/0000-0003-3881-7895
Kawakami, Akinori https://orcid.org/0000-0001-7239-7236
Shen, Hongying https://orcid.org/0000-0002-2115-7037
Kemény, Lajos V.
Joesch-Cohen, Lena
Rees, Matthew G. https://orcid.org/0000-0002-2987-7581
Roth, Jennifer A. https://orcid.org/0000-0002-5117-5586
Fisher, David E.
Mootha, Vamsi K. https://orcid.org/0000-0001-9924-642X
Jourdain, Alexis A. https://orcid.org/0000-0001-5321-6938
- License Information
-
More Information
Article History
Received: 3 February 2023
Accepted: 3 March 2023
First Online: 17 May 2023
Competing interests
: V.K.M. is a paid scientific advisor to 5AM Ventures. O.S.S. was a paid consultant for Proteinaceous Inc. D.E.F. has a financial interest in Soltego, a company developing salt-inducible kinase inhibitors for topical skin-darkening treatments that might be used for a broad set of human applications. The interests of D.E.F. were reviewed and are managed by Massachusetts General Hospital and Partners HealthCare in accordance with their conflict-of-interest policies. The remaining authors declare no competing interests.
